Find a Clinical Trial | American Lung Association

Improving Medication Adherence with Telehealthcare Medication Therapy Management to Change Health Outcomes in Adolescents and Young Adults with Asthma (MATCH)

The ACRC network is studying whether having regular telehealth appointments with a pharmacist using a study provided tablet or a person’s smart phone or computer will help adolescents and young adults with asthma to gain control of asthma symptoms and improve inhaler effectiveness.

INTerpath-013

The goal of this study is to learn if people who receive intismeran autogene and pembrolizumab after surgery are cancer-free longer than people who receive placebo and pembrolizumab. Researchers want to know if giving intismeran autogene and pembrolizumab after surgery can help prevent the cancer from coming back in people with non-small cell lung cancer (NSCLC) whose tumors did not respond completely to treatment before surgery (neoadjuvant treatment).

IZABRIGHT-Lung01

A Study of Izalontamab Brengitecan (BMS-986507) versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer after failure of EGFR TKI Therapy

KANDLELIT-004

KEYLYNK-012

This study is looking at how pembrolizumab with chemotherapy and radiation followed by pembrolizumab plus olaparib (or placebo for olaparib) works compared to chemotherapy and radiation followed by durvalumab.

KEYLYNK-013

This clinical trial is trying to find out if a combination of study drugs can help stop or slow down this type of cancer.

KEYMAKER-U01-01F

Researchers want to learn if MK-1084, the study medicine, can treat advanced or metastatic non-squamous NSCLC. MK-1084 is a targeted therapy, which is a treatment that works to control how specific types of cancer cells grow and spread. The goals of this study are to learn 1) about the safety of MK-1084 and if people tolerate it when taken with other treatments and 2) how many people have the cancer respond (get smaller or go away) to the treatments.

KEYMAKER-U01-01H

Researchers will compare 2 different ADCs (the study treatments) to chemotherapy in this study. The goals of this study are to learn 1) about the safety of the study treatments and if people tolerate them and 2) how many people have the cancer respond to the study treatments.

KEYMAKER-U01-01I

Researchers want to learn if study treatments that are antibody drug conjugates (ADCs) can treat metastatic squamous NSCLC that did not respond (get smaller or go away) to standard treatment. The main goals of this study are to learn about 1) the cancer response to the study treatments compared to chemotherapy and 2) the safety of the study treatments and if people tolerate them.

KEYMAKER-U01-01J

Researchers want to learn if using a study medicine called MK-1084 can help treat NSCLC. MK-1084 is a type of treatment called targeted therapy for the Kirsten rat sarcoma viral oncogene homolog (KRAS) G12C gene change. The goal of this study is to learn about the safety of MK-1084 and to learn how many people have the cancer get smaller or go away during the study treatment.

Next